MCAM and breast cancer: Indeed, when over-expressed in epithelial breast cancer cells, CD146 down-regulates the epithelial markers while it up-regulates the mesenchymal markers, which significantly results in an increased cell migration and invasion ability along with an increase in Cancer Stem Cell (CSC) properties [13,14].